Depot medroxyprogesterone acetate: A risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?

Tovia Elizabeth Martirosian, Steven Christopher Smith, Alexander Baras, Mixon M. Darracott

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: In our anecdotal experience and sporadically in the literature, gynecologists have observed a connection between patient's use of depot medroxyprogesterone acetate (DMPA) and increased occurrence of cervical stenosis during follow-up after loop electrosurgical excisional procedure (LEEP). We decided to formally examine this association in our clinic population. MATERIALS AND METHODS: We performed a chart review, enrolling 257 patients and tabulating data on demography, use of hormonal contraceptives, characteristics of the LEEP, and presence or absence of cervical stenosis at 1- and 6-month follow-up evaluations. Univariate tests of association between the independent variables and the dependent variable of cervical stenosis were examined via the χ and Student t tests for discrete and continuous variables, respectively. To characterize the relative importance of independent variables significantly associated with cervical stenosis, logistic regression was performed. RESULTS: Of the 257 charts reviewed, 127 patients (49.4%) completed 1 and 6 months after LEEP follow-up appointments, providing adequate data for analysis. In this population, we observed 25 cases of cervical stenosis, or an overall rate of 19.7%. Of patients using DMPA at the time of LEEP or during the follow-up period, 9 (41.0%) of 22 developed stenosis, whereas of those who did not use DMPA, 16 (15.2%) of 105 developed stenosis, indicating a significant difference (odds ratio = 3.85, 95% CI = 1.41-10.50). CONCLUSIONS: In our clinic population, use of DMPA was associated with higher rates of development of cervical stenosis, calling for larger studies of the association of DMPA in this LEEP complication.

Original languageEnglish (US)
Pages (from-to)37-42
Number of pages6
JournalJournal of Lower Genital Tract Disease
Volume14
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Medroxyprogesterone Acetate
Cervical Intraepithelial Neoplasia
Pathologic Constriction
Population
Contraceptive Agents
Appointments and Schedules
Logistic Models
Odds Ratio
Demography
Students

Keywords

  • Cervical intraepithelial neoplasia
  • Cervical stenosis
  • LEEP
  • Medroxyprogesterone acetate

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Depot medroxyprogesterone acetate : A risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia? / Martirosian, Tovia Elizabeth; Smith, Steven Christopher; Baras, Alexander; Darracott, Mixon M.

In: Journal of Lower Genital Tract Disease, Vol. 14, No. 1, 01.2010, p. 37-42.

Research output: Contribution to journalArticle

@article{2c999f5cef484ab1bc9a89e0fa225bf7,
title = "Depot medroxyprogesterone acetate: A risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?",
abstract = "OBJECTIVES: In our anecdotal experience and sporadically in the literature, gynecologists have observed a connection between patient's use of depot medroxyprogesterone acetate (DMPA) and increased occurrence of cervical stenosis during follow-up after loop electrosurgical excisional procedure (LEEP). We decided to formally examine this association in our clinic population. MATERIALS AND METHODS: We performed a chart review, enrolling 257 patients and tabulating data on demography, use of hormonal contraceptives, characteristics of the LEEP, and presence or absence of cervical stenosis at 1- and 6-month follow-up evaluations. Univariate tests of association between the independent variables and the dependent variable of cervical stenosis were examined via the χ and Student t tests for discrete and continuous variables, respectively. To characterize the relative importance of independent variables significantly associated with cervical stenosis, logistic regression was performed. RESULTS: Of the 257 charts reviewed, 127 patients (49.4{\%}) completed 1 and 6 months after LEEP follow-up appointments, providing adequate data for analysis. In this population, we observed 25 cases of cervical stenosis, or an overall rate of 19.7{\%}. Of patients using DMPA at the time of LEEP or during the follow-up period, 9 (41.0{\%}) of 22 developed stenosis, whereas of those who did not use DMPA, 16 (15.2{\%}) of 105 developed stenosis, indicating a significant difference (odds ratio = 3.85, 95{\%} CI = 1.41-10.50). CONCLUSIONS: In our clinic population, use of DMPA was associated with higher rates of development of cervical stenosis, calling for larger studies of the association of DMPA in this LEEP complication.",
keywords = "Cervical intraepithelial neoplasia, Cervical stenosis, LEEP, Medroxyprogesterone acetate",
author = "Martirosian, {Tovia Elizabeth} and Smith, {Steven Christopher} and Alexander Baras and Darracott, {Mixon M.}",
year = "2010",
month = "1",
doi = "10.1097/LGT.0b013e3181b0f73f",
language = "English (US)",
volume = "14",
pages = "37--42",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Depot medroxyprogesterone acetate

T2 - A risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?

AU - Martirosian, Tovia Elizabeth

AU - Smith, Steven Christopher

AU - Baras, Alexander

AU - Darracott, Mixon M.

PY - 2010/1

Y1 - 2010/1

N2 - OBJECTIVES: In our anecdotal experience and sporadically in the literature, gynecologists have observed a connection between patient's use of depot medroxyprogesterone acetate (DMPA) and increased occurrence of cervical stenosis during follow-up after loop electrosurgical excisional procedure (LEEP). We decided to formally examine this association in our clinic population. MATERIALS AND METHODS: We performed a chart review, enrolling 257 patients and tabulating data on demography, use of hormonal contraceptives, characteristics of the LEEP, and presence or absence of cervical stenosis at 1- and 6-month follow-up evaluations. Univariate tests of association between the independent variables and the dependent variable of cervical stenosis were examined via the χ and Student t tests for discrete and continuous variables, respectively. To characterize the relative importance of independent variables significantly associated with cervical stenosis, logistic regression was performed. RESULTS: Of the 257 charts reviewed, 127 patients (49.4%) completed 1 and 6 months after LEEP follow-up appointments, providing adequate data for analysis. In this population, we observed 25 cases of cervical stenosis, or an overall rate of 19.7%. Of patients using DMPA at the time of LEEP or during the follow-up period, 9 (41.0%) of 22 developed stenosis, whereas of those who did not use DMPA, 16 (15.2%) of 105 developed stenosis, indicating a significant difference (odds ratio = 3.85, 95% CI = 1.41-10.50). CONCLUSIONS: In our clinic population, use of DMPA was associated with higher rates of development of cervical stenosis, calling for larger studies of the association of DMPA in this LEEP complication.

AB - OBJECTIVES: In our anecdotal experience and sporadically in the literature, gynecologists have observed a connection between patient's use of depot medroxyprogesterone acetate (DMPA) and increased occurrence of cervical stenosis during follow-up after loop electrosurgical excisional procedure (LEEP). We decided to formally examine this association in our clinic population. MATERIALS AND METHODS: We performed a chart review, enrolling 257 patients and tabulating data on demography, use of hormonal contraceptives, characteristics of the LEEP, and presence or absence of cervical stenosis at 1- and 6-month follow-up evaluations. Univariate tests of association between the independent variables and the dependent variable of cervical stenosis were examined via the χ and Student t tests for discrete and continuous variables, respectively. To characterize the relative importance of independent variables significantly associated with cervical stenosis, logistic regression was performed. RESULTS: Of the 257 charts reviewed, 127 patients (49.4%) completed 1 and 6 months after LEEP follow-up appointments, providing adequate data for analysis. In this population, we observed 25 cases of cervical stenosis, or an overall rate of 19.7%. Of patients using DMPA at the time of LEEP or during the follow-up period, 9 (41.0%) of 22 developed stenosis, whereas of those who did not use DMPA, 16 (15.2%) of 105 developed stenosis, indicating a significant difference (odds ratio = 3.85, 95% CI = 1.41-10.50). CONCLUSIONS: In our clinic population, use of DMPA was associated with higher rates of development of cervical stenosis, calling for larger studies of the association of DMPA in this LEEP complication.

KW - Cervical intraepithelial neoplasia

KW - Cervical stenosis

KW - LEEP

KW - Medroxyprogesterone acetate

UR - http://www.scopus.com/inward/record.url?scp=76149132321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149132321&partnerID=8YFLogxK

U2 - 10.1097/LGT.0b013e3181b0f73f

DO - 10.1097/LGT.0b013e3181b0f73f

M3 - Article

C2 - 20040834

AN - SCOPUS:76149132321

VL - 14

SP - 37

EP - 42

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 1

ER -